Ansell Ltd (ASX: ANN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ansell Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.48 billion
P/E Ratio 11.09
Dividend Yield 3.46%
Shares Outstanding 127.84 million
Earnings per share 1.681
Dividend per share 0.93
Year To Date Return -13.56%
Earnings Yield 9.02%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Ansell Ltd (ASX: ANN)
Latest News

three boxers, two men and a woman, stand in their training wear with fists raised in a fighting stance with serious looks on their faces against a background of a boxing gym.
Share Market News

3 beaten-up ASX All Ordinaries shares that surged higher today

These All Ordinaries shares have struggled lately but they were among the leaders of the pack today.

Read more »

A middle-aged woman sits in contemplation over a tablet device considering information about ASX shares and deep in thought.
Dividend Investing

2 top ASX dividend shares to think about

Ansell is one ASX dividend share, but it has taken a dive recently.

Read more »

Santos Oil Search ASX share price movements represented by street signs stating mergers and acquisitions bluescope share price
Mergers & Acquisitions

5 ASX shares that could be primed for takeovers in 2022: Wilsons

2021 was a record year for takeovers in the listed Aussie market, and 2022 could yet see even more M&A…

Read more »

Man presses green buy button and red sell button on a graph.
Broker Notes

Top brokers name 3 ASX shares to buy today

Brokers are feeling bullish about these ASX shares...

Read more »

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.
Share Market News

ASX 200 (ASX:XJO) midday update: BHP and SEEK impress, Beach sinks

A lot is happening on the ASX 200 on Tuesday...

Read more »

Health professional putting on gloves.
Earnings Results

Ansell (ASX:ANN) share price gains despite profits tumbling 27% in ‘challenging’ half

The first half was a tough slog for the personal safety and protection equipment manufacturer.

Read more »

Close up of a sad young Caucasian woman reading about Leigh Creek Energy's declining share price on her phone
Share Fallers

These were the worst performing ASX 200 shares last week

These ASX 200 shares were sold off last week...

Read more »

share price battering and recovery, child with black eye and boxing gloves
Industrials Shares

Down 20% in 2022, is the Ansell (ASX:ANN) share price a bargain buy?

Ansell shares have suffered in 2022. But is it now an opportunity?

Read more »

Frequently Asked Questions

Ansell’s most recent dividend payment was an interim dividend of 32.88 cents in March 2020, which was unfranked. Thus far, it has not made any announcements regarding further dividend payments in 2020.

Yes, Ansell offers a dividend reinvestment plan (DRP) as an alternative to receiving cash dividends on Ansell ordinary shares.

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
21 Feb 2022 $0.3367 0.00% Interim 09 Mar 2022
30 Aug 2021 $0.5944 0.00% Final 16 Sep 2021
22 Feb 2021 $0.4190 0.00% Interim 10 Mar 2021
31 Aug 2020 $0.3811 0.00% Final 17 Sep 2020
24 Feb 2020 $0.3288 0.00% Interim 12 Mar 2020
16 Aug 2019 $0.3833 0.00% Final 05 Sep 2019
22 Feb 2019 $0.5830 50.17% Interim 14 Mar 2019
24 Aug 2018 $0.3414 0.00% Final 13 Sep 2018
16 Feb 2018 $0.2588 44.13% Interim 08 Mar 2018
18 Aug 2017 $0.2998 0.00% Final 08 Sep 2017
17 Feb 2017 $0.2638 0.00% Interim 10 Mar 2017
19 Aug 2016 $0.3097 0.00% Final 08 Sep 2016
11 Feb 2016 $0.2795 0.00% Interim 10 Mar 2016
13 Aug 2015 $0.3119 0.00% Final 10 Sep 2015
12 Feb 2015 $0.2567 0.00% Interim 11 Mar 2015
28 Aug 2014 $0.2357 0.00% 24 Sep 2014
26 Feb 2014 $0.1828 0.00% Interim 25 Mar 2014
16 Feb 2012 $0.1500 0.00% Interim 14 Mar 2012
17 Feb 2011 $0.1400 0.00% Interim 16 Mar 2011
31 Aug 2010 $0.1750 0.00% Final 29 Sep 2010
11 Mar 2005 $0.0700 57.14% 08 Apr 2005

ANN ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Ansell Ltd

Ansell Limited (ASX: ANN) is a global leader in health and safety protection solutions. The company operates in two main business segments, healthcare and industrial, to provide a range of personal protective equipment and safety devices.

Starting out from humble beginnings as a condom manufacturer in the early 1900s, Ansell is now known for primarily manufacturing a range of gloves using different materials for varying uses. With this, the company manufactures more than 10 billion gloves per year and protects more than 10 million people each day. Ansell provides protection solutions to more than 25 industries and has customers in over 100 countries across the globe.

In 1969, Ansell was acquired by Pacific Dunlop, an Australian conglomerate that was once one of the largest companies in the country. However, after selling and spinning off most of its businesses, Pacific Dunlop was renamed Ansell in 2002. Since then, the Ansell share price has gone from strength to strength, delivering capital gains to many shareholders over the years as well as income in the form of dividends.

ANN Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 May 2022 $27.24 $0.34 1.26% 372,264 $27.21 $27.42 $27.03
13 May 2022 $26.90 $0.61 2.32% 298,602 $26.45 $26.95 $26.04
12 May 2022 $26.29 $-0.32 -1.20% 345,677 $26.47 $26.53 $26.03
11 May 2022 $26.61 $0.50 1.91% 400,802 $26.11 $26.73 $25.93
10 May 2022 $26.11 $-0.32 -1.21% 456,764 $26.32 $26.35 $25.66
09 May 2022 $26.43 $-0.18 -0.68% 487,915 $26.54 $26.87 $26.18
06 May 2022 $26.61 $-0.28 -1.04% 330,179 $26.67 $26.78 $26.37
05 May 2022 $26.89 $-0.48 -1.75% 632,623 $27.44 $27.44 $26.76
04 May 2022 $27.37 $0.12 0.44% 542,682 $27.50 $27.93 $27.29
03 May 2022 $27.25 $0.17 0.63% 372,608 $27.11 $27.46 $27.02
02 May 2022 $27.08 $-0.24 -0.88% 520,921 $27.16 $27.36 $26.83
29 Apr 2022 $27.32 $1.10 4.20% 840,185 $26.34 $27.34 $26.30
28 Apr 2022 $26.22 $0.47 1.83% 375,109 $25.81 $26.26 $25.64
27 Apr 2022 $25.75 $-0.63 -2.39% 680,638 $26.14 $26.41 $25.26
26 Apr 2022 $26.38 $0.23 0.88% 684,069 $26.13 $26.80 $25.86
22 Apr 2022 $26.15 $0.06 0.23% 380,902 $25.89 $26.34 $25.75
21 Apr 2022 $26.09 $-0.05 -0.19% 329,359 $26.20 $26.45 $25.83
20 Apr 2022 $26.14 $0.87 3.44% 616,679 $25.37 $26.15 $25.37

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
29 Apr 2022 John Bevan Buy 124 $3,380
Participation in share purchase plan.
29 Apr 2022 Christina Stercken Buy 181 $4,934
Participation in share purchase plan.
29 Apr 2022 Christine Yan Buy 194 $5,288
Participation in share purchase plan.
31 Mar 2022 Christine Yan Buy 212 $5,505
Participation in share purchase plan.
31 Mar 2022 Christina Stercken Buy 196 $5,089
Participation in share purchase plan.
31 Mar 2022 John Bevan Buy 135 $3,505
Participation in share purchase plan.
15 Mar 2022 Nigel Garrard Buy 500 $12,250
On-market trade.
08 Mar 2022 Nigel Garrard Buy 500 $12,600
On-market trade.
01 Mar 2022 John Bevan Buy 138 $3,596
Participation in share purchase plan.
01 Mar 2022 Christina Stercken Buy 200 $5,212
Participation in share purchase plan.
01 Mar 2022 Christine Yan Buy 215 $5,602
Participation in share purchase plan.
18 Feb 2022 Christine Yan Buy 207 $5,534
Participation in share purchase plan.
18 Feb 2022 Christina Stercken Buy 192 $5,133
Participation in share purchase plan.
18 Feb 2022 John Bevan Buy 132 $3,529
Participation in share purchase plan.
31 Dec 2021 Christina Stercken Buy 160 $5,254
Participation in share purchase plan.
31 Dec 2021 John Bevan Buy 105 $3,448
Participation in share purchase plan.
31 Dec 2021 Christine Yan Buy 173 $5,681
Participation in share purchase plan.
30 Nov 2021 Christine Yan Buy 165 $5,369
Participation in share purchase plan.
30 Nov 2021 John Bevan Buy 101 $3,286
Participation in share purchase plan.
30 Nov 2021 Christina Stercken Buy 153 $4,978
Participation in share purchase plan.
11 Nov 2021 William Day Transfer 8 $281,092
Off-market transfer. Assuming 8,972 direct shares transferred to indirect shares
11 Nov 2021 William Day Transfer 8 $281,092
Off-market transfer. Assuming 8,972 direct shares transferred to indirect shares
29 Oct 2021 John Bevan Buy 105 $3,349
Participation in share purchase plan.
29 Oct 2021 Christina Stercken Buy 160 $5,104
Participation in share purchase plan.
29 Oct 2021 Christine Yan Buy 172 $5,486
Participation in share purchase plan.
30 Sep 2021 Christine Yan Buy 159 $5,428
Participation in share purchase plan.
30 Sep 2021 Christina Stercken Buy 147 $5,018
Participation in share purchase plan.
30 Sep 2021 John Bevan Buy 97 $3,311
Participation in share purchase plan.
31 Aug 2021 Magnus Nicolin Exercise 184 $6,675,970
Conversion of securities. 184,621 - performance share rights
As per announcement on 02/09/2021
31 Aug 2021 Magnus Nicolin Buy 184 $6,675,970
Conversion of securities.
31 Aug 2021 Magnus Nicolin Sell 70 $2,553,558
On-market trade.
31 Aug 2021 John Bevan Buy 92 $3,303
Participation in share purchase plan.
31 Aug 2021 Christina Stercken Buy 152 $5,458
Participation in share purchase plan.
31 Aug 2021 Christine Yan Buy 165 $5,925
Participation in share purchase plan.
27 Aug 2021 Nigel Garrard Buy 1 $36,375
On-market trade.
26 Aug 2021 John Bevan Buy 90 $3,289
Participation in share purchase plan.
26 Aug 2021 Christina Stercken Buy 124 $4,532
Participation in share purchase plan.
26 Aug 2021 Christine Yan Buy 133 $4,861
Participation in share purchase plan.
30 Jun 2021 Christine Yan Buy 104 $4,567
Participation in share purchase plan.
30 Jun 2021 Christina Stercken Buy 70 $3,074
Participation in share purchase plan.
30 Jun 2021 Leslie Desjardins Buy 78 $3,425
Participation in share purchase plan.
30 Jun 2021 John Bevan Buy 144 $6,324
Participation in share purchase plan.
31 May 2021 John Bevan Buy 153 $6,316
Participation in share purchase plan.
31 May 2021 Leslie Desjardins Buy 83 $3,426
Participation in share purchase plan.
31 May 2021 Christina Stercken Buy 73 $3,013
Participation in share purchase plan.
31 May 2021 Christine Yan Buy 110 $4,541
Participation in share purchase plan.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Nigel David Garrard Non-Executive Director Mar 2020
Mr Garrard is an experienced executive with a track record across FMCG and Industrial/Manufacturing sectors. Mr Garrard has 20 year's experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Mr Garrard was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division and Managing Director of SPC Ardmona. Mr Garrard brings international experience across listed, not-for-profit, government and private entities. He is the Member of the Human Resources Committee (Chair from 1 July 2021) and member of the Sustainability and Risk Committee. He is Chairman of McMahon Services, Non-Executive Director of Hudson Institute of Medical Research and CSR Ltd . Previous Directorships include Managing Director of Orora Limited, Managing Director of Amcor Australasia and Packaging Distribution , Managing Director of SPC Ardmona Limited , Managing Director of Chiquita Brands South Pacific Ltd.

Mr William G Reilly Non-Executive Director Oct 2017
Mr Reilly has over 35 years experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002. Mr Reilly has served with three Chief Executive Officers and has played pivotal roles leading many of Ansell's corporate strategic and legal initiatives, including M&A, litigation and the successful intellectual property strategy. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. Prior to joining Ansell, Mr Reilly held senior legal positions at C. R. Bard, Inc., The Hertz Corporation and McKesson Corporation. In 2016, Mr Reilly was named on the Financial Times first ever Global GC 30 List. Mr Reilly is Member of the Sustainability and Risk Committee, the Human Resources Committee and the Governance Committee.
Mr John Andrew Bevan Non-Executive DirectorNon-Executive Chairman Aug 2012
Mr Bevan was formerly the Chief Executive Officer and Executive Director of Alumina Limited and brings to the Board international business experience. Prior to joining Alumina Limited, he had a career with the BOC Group Plc, where he was a member of the Board of Directors and held a variety of senior management positions in Australia, Korea, Thailand, Singapore and the UK. He is Chair of the Governance Committee and member of the Human Resources Committee. He is Chairman of BlueScope Steel Limited, Non-Executive Director of Humpty Dumpty Foundation and Alumina Limited and Former Director of Non-Executive Director of Nuplex Industries Limited, Executive Director of Alumina Limited.

Ms Leslie A Desjardins Non-Executive Director Nov 2015
Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the US and Australia, including Chief Financial Officer GM Holden, Controller for GM North America, and Finance Director for GM's manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is member of the Sustainability and Risk Committee. She is the Non-Executive Director and Audit and Risk Committee Chair of ALS Limited, Non-Executive Director and Audit Committee Chair of Terry Fox Cancer Foundation and Former Director of Aptar Group.
Mrs Christina Stercken Non-Executive Director Oct 2017
Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A and operational excellence in growth markets. Before joining EAC, Mrs Stercken served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. Mrs Stercken brings a range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. In her function as Vice Chairman of Myanmar Foundation, Munich, Mrs Stercken supports social Stercken supports social projects in Myanmar. She is the Member of the Sustainability and Risk Committee.She is director of Landis & Gyr Group AG , Myanmar Foundation (Vice Chairman and Former Director of Ascom Holding AG.

Ms Christine Yingli Yan Non-Executive Director Feb 2019
Ms Yan is an experienced executive who has had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings a range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation and marketing in the businessto- business industry. She is the Member of the Human Resources Committee. She is currently Non-Executive Director of ON Semiconductor Corporation, Non- Executive Director of Modine Manufacturing Company Inc. and Non-Executive Director of Cabot Corporation.
Mr Neil Salmon Chief Executive OfficerManaging Director Sep 2021
Mr Salmon is currently President of the Industrial Global Business Unit, having served as Chief Financial officer for 6 years. Neil has more than 20 years of experience, gained working across a range of roles in a group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the US and Singapore. After ICI he served as Chief Financial Officer of Innophos in New Jersey, prior to joining Ansell.
Morten Falkenberg Non-Executive Director Nov 2021
--
Ms Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary Apr 2017
-
Zubair Javeed Chief Financial Officer
-
Darryl Nazareth President of the Healthcare GBU (HGBU)
-
Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 46,082,341 36.00%
J P Morgan Nominees Australia Pty Limited 19,774,760 15.45%
Citicorp Nominees Pty Limited 12,892,489 10.07%
National Nominees Limited 6,829,707 5.34%
HSBC Custody Nominees (Australia) Limited (I) 2,117,496 1.65%
BNP Paribas Noms Pty Ltd (DRP) 1,665,259 1.30%
BNP Paribas Nominees Pty Ltd (Agency Lending DRP A/C) 1,490,115 1.16%
Australian Foundation Investment Company Limited 1,078,865 0.84%
Netwealth Investments Limited (Wrap Services A/C) 763,076 0.60%
CPU Share Plans Pty Ltd (PSR Nor Unallocated A/C) 700,000 0.55%
National Nominees Limited (DB A/C) 668,908 0.52%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (DRP A/C) 611,184 0.48%
HSBC Custody Nominees (Australia) Limited A/C 2 409,607 0.32%
BNP Paribas Nominees Pty Ltd Six Sis Ltd (DRP A/C) 389,719 0.30%
Citicorp Nominees Pty Limited (Colonial First State Inv A/C) 383,789 0.30%
Australian Executor Trustees Limited (No 1 Account) 304,745 0.24%
AMP Life Limited 285,423 0.22%
Mirrabooka Investments Limited 273,499 0.21%
BNP Paribas Noms (NZ) Ltd (DRP) 259,347 0.20%
Australian Executor Trustees Limited (IPS Super A/C) 243,535 0.19%

Profile

since

Note